Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
15,650
Total Claims
$1.5M
Drug Cost
463
Beneficiaries
$3,257
Cost/Patient
Risk Score Breakdown 36/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+89%
Opioid rate vs peers
4.9% vs 2.6% avg
+205%
Cost per patient vs peers
$3,257 vs $1,068 avg
+79%
Brand preference vs peers
16.1% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.9%
Opioid Rate
763
Opioid Claims
$34K
Opioid Cost
31.5%
Long-Acting Rate
Brand vs Generic
Brand: 2,512 claims · $1.3M
Generic: 13,047 claims · $238K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 103 | $101K |
| Empagliflozin | 151 | $94K |
| Apixaban | 172 | $87K |
| Linaclotide | 164 | $80K |
| Dapagliflozin Propanediol | 121 | $80K |
| Rivaroxaban | 169 | $62K |
| Dulaglutide | 49 | $56K |
| Fluticasone/Umeclidin/Vilanter | 74 | $50K |
| Mirabegron | 171 | $49K |
| Lipase/Protease/Amylase | 30 | $45K |
| Sitagliptin Phosphate | 87 | $40K |
| Vibegron | 81 | $33K |
| Brexpiprazole | 18 | $27K |
| Insulin Degludec | 27 | $23K |
| Semaglutide | 24 | $22K |
Prescribing Profile
Patient Profile
73
Avg Age
50%
Female
1.56
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About